Sol-Gel Provides Product Pipeline Updates and Anticipated Milestones for 2020GlobeNewsWire • 02/05/20
Sol-Gel Shines In Treating 2 Skin Disorders, NDAs Expected For Both Indications In 2020Seeking Alpha • 01/08/20
Sol-Gel Announces Initiation of SGT-210 Phase 1 Proof of Concept Study in Palmoplantar Keratoderma (PPK)GlobeNewsWire • 01/02/20
Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of Twyneo® for the Treatment of Acne VulgarisGlobeNewsWire • 12/30/19
Sol-Gel to Present on Potential of Sol-Gel Microencapsulation Technology in Rosacea at 39th Annual Fall Clinical Dermatology ConferenceGlobeNewsWire • 10/16/19
Sol-Gel Technologies Ltd. (SLGL) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 08/07/19
Sol-Gel Technologies reports positive results in trials of treatment for papulopustular rosaceaMarket Watch • 07/08/19
Analysts Estimate Sol-Gel Technologies Ltd. (SLGL) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 05/14/19